Tuesday, August 21, 2018
PPMA – event – sep 2018

Latest news

Tolero working with AbbVie on potential AML treatment

Tolero working with AbbVie on potential AML treatment

Tolero Pharmaceuticals aims to explore the potential combination therapy of its investigational agent alvocidib with AbbVie’s venetoclax for treating relapsed/refractory acute myeloid leukemia (AML). Alvocidib...
Orkambi recommended to treated Australians with cystic fibrosis

Orkambi recommended to treated Australians with cystic fibrosis

The Pharmaceutical Benefits Advisory Committee (PBAC) have recommended Orkambi to be listed on the Pharmaceutical Benefits Scheme in Australia for people ages six and...
Opdivo approved in US for treating small cell lung cancer

Opdivo approved in US for treating small cell lung cancer

The FDA has approved Bristol-Myers Squibb’s Opdivo as the first and only immuno-oncology treatment option for patients with previously treated metastatic small cell lung...